The WHO said a sample database from nations around the world has shown the presence of the B.1.617 variant. Meanwhile, Canada's largest province has suspended use of the AstraZeneca vaccine. Follow DW for the latest.
Message :
Required fields
LA PAZ/TORONTO, May 11 (Reuters) - Bolivia s government said
on Tuesday it had signed a deal for a potential 15 million
Johnson & Johnson COVID-19 vaccines but with a twist:
another manufacture would make the shots and Bolivia would need
the World Trade Organization to waive the drug s patent.
The South American country, scrabbling for vaccines like
many in the region, said it had applied to the WTO to
green-light a vaccine waiver so Canadian company Biolyse Pharma
Corp could make the doses.
Bolivian trade official Benjamin Blanco told a news
conference the move could help the impoverished Andean nation
By Danny Ramos and Allison Martell LA PAZ/TORONTO (Reuters) - Bolivia's government said on Tuesday it had signed a deal for a potential 15 million Joh.
New COVID-19 variant drives infections in India
Worldwide
The WHO said on Wednesday that the so-called Indian variant of coronavirus has now been detected in 44 countries in all six WHO regions. The UN health agency based its findings on 4,500 samples uploaded on an open-access database.
The variant, which is known as B.1.617, is believed to be one of several factors behind the massive outbreak in infections across India. Outside of India, the UK has reported the highest number of COVID cases caused by the Indian variant.
World leaders, and the World Health Organization, could have done more to lessen the deadly effects of the coronavirus pandemic, according to a report issued at the request of the WHO by the Independent Panel for Pandemic Preparedness and Response.